Navigation Links
Qnexa® Phase 3 Data Published In Obesity Show 14.4% Average Weight Loss In Severely Obese Patients Completing One Year Of Treatment
Date:11/3/2011

velopment for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity," "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the response from the United States Food and Drug Administration, or FDA, to our resubmission of the New Drug Application, or NDA, for Qnexa for the treatment of obesity, including weight loss and maintenance of weight loss, recommended for obese patients (BMI >/= 30 kg/m2), or overweight patients (BMI >/= 27 kg/m2) with weight-related co-morbidities such as hypertension, type 2 diabetes, dyslipidemia, or central adiposity (abdominal obesity), with a contraindication that excludes the use of Qnexa by women of child-bearing potential; the timing and results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy; the reliability of the electronic medical claims healthcare databases used in the FORTRESS study; the FDA's interpretation of and agreement with the information VIVUS submitted relating to teratogenicity and cardiovascular safety; the FDA's interpretation of the data from our SEQUEL study (OB-305) and Sleep Apnea study (OB-204); that we may be required to conduct additional prospective studies or retr
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Multiple Presentations Featuring QNEXA® Data to be Presented at the European Congress on Obesity
2. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
3. Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
4. Long-Term Data on QNEXA® to be Presented at The American College of Cardiology Annual Meeting
5. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
6. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
7. New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years
8. Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes
9. Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
10. Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
11. Cytogel Pharma, LLC. Announces Presentation at the American Society of Anesthesiologists meeting in Chicago on October 18, 2011, Describing Results From its First Human Study, Part of the Phase I Program for Cyt-1010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)...  Alere Inc. (NYSE: ALR ), a ... today in support of President Barack Obama,s ... global leader in rapid diagnostics for infectious disease, we ... address the serious threat of antibiotic resistance. We look ... initiatives to promote the development of rapid point-of-care tests ...
(Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
(Date:9/19/2014)... , Sept. 19, 2014  The body of ... the publication of two papers this past week.  The ... Head and Neck Surgery , finds that withholding ... subjective measures of sleep disordered breathing, leading the paper,s ... in obstructive sleep apnea severity and improvement of quality ...
Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... Amex: CXM ) today provided an update regarding ... assets in connection with a proposed asset purchase under Chapter ... 27, 2011, the completion of such an asset purchase is ... bankruptcy court.  In an effort to expedite the proposed transaction, ...
... The National Association of Boards of ... Americans about the serious dangers associated with medicines purchased ... on Internet drug outlets found that 96% of 8,000 ... compliance with United States pharmacy laws, fuel prescription drug ...
Cached Medicine Technology:Cardium Reports on Transdel Transaction 2Cardium Reports on Transdel Transaction 3Cardium Reports on Transdel Transaction 4NABP Issues Rogue Online Pharmacy Public Health Alert 2NABP Issues Rogue Online Pharmacy Public Health Alert 3NABP Issues Rogue Online Pharmacy Public Health Alert 4
(Date:9/22/2014)... Mississauga, Ontario (PRWEB) September 22, 2014 ... August 1st, 2014 at the PWN International Conference in ... Canadian release that was celebrated with a reception attended ... this reception Dawn shared insights she had gained while ... organizational side of the glass ceiling issue, and what ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Fancyflyingfox.com, the well-known ... collection of 2014 plus size wedding dresses . In ... offer for these fashionable plus size outfits. Each item in ... price, up to 65% off. , The company has ... of them are now available at extremely affordable prices. Its ...
(Date:9/21/2014)... September 22, 2014 CareSpan USA, Inc. ... entered into a joint services agreement with Avera eCARE, ... deploy the CareSpan Virtual Clinic in multiple states where ... plan to deploy their joint services in remote and ... where Avera eCARE is licensed. The two companies’ strategy ...
(Date:9/21/2014)... study of cancer patients who smoke, those using e-cigarettes ... and equally or less likely to have quit smoking ... Cancer , a peer-reviewed journal of the American Cancer ... of e-cigarettes for helping cancer patients give up smoking. ... cancer patients who smoke should be advised to quit. ...
(Date:9/21/2014)... of the leading online stores of real and synthetic hair ... human hair lace wigs inspired by 6 famous celebrities. It’s ... latest celebrity hairstyles are. , For people who ... to choose from: a style of yaki straight lace wig, ... ombre red lace wig. People can go to the product ...
Breaking Medicine News(10 mins):Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Discounted Plus Size Wedding Dresses Available At Fancyflyingfox.com 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2
... looking to benefit from the lucrative coaching market , ... Cincinnati (PRWEB) ... employee wellness market. Companies interested in exploiting this market opportunity face ... goal of controlling skyrocketing health insurance costs, a third of organizations already ...
... Space Shuttle delivered high-resolution video , ... Van Nuys, ... leader in high-quality lenses for industrial applications, has just announced that ... to play an important role in the recent servicing in orbit ...
... Metropolitan area physicians , ... Rye Brook, N.Y. (PRWEB) ... providers of specialized anatomic pathology services, today announced the opening of ... enhance services for Metropolitan area physicians. Licensed by the New York ...
... Federal And State Dollar Spent, 96 Cents Goes to Shovel ... Goes to Prevention and TreatmentWASHINGTON, May 28 ... at least $467.7 billion in 2005, according to Shoveling ... and Local Budgets, a new 287-page report released today ...
... Construction and Sleep Experts have been honored as ... Ethics Awards. Two area medical facilities, Texas Institute ... were among the nine finalists.The other 2009 finalists ... Aspire, Cadence McShane Construction Company and The Dwyer ...
... Texas; PHILADELPHIA The Lance Armstrong Foundation (LAF) ... to further develop and disseminate the LIVESTRONG Care ... service gives cancer survivors, their families and physicians ... care using up-to-date treatment information based on Institute ...
Cached Medicine News:Health News:Hummingbird Coaching's New White Paper on Health Coaching: Build it or Buy it? 2Health News:Hummingbird Coaching's New White Paper on Health Coaching: Build it or Buy it? 3Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 2Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 3Health News:CBLPath Opens Manhattan Facility 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 2Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 3Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 4Health News:New CASA* Report Finds Federal, State and Local Governments Spend Almost Half a Trillion Dollars a Year on Substance Abuse and Addiction 5Health News:Medical Facilities Among Finalists for Greater Dallas Business Ethics Awards 2Health News:LIVESTRONG and Penn Medicine announce partnership to bring online care plan tool to cancer survivors 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: